Classé J G
J Am Optom Assoc. 1980 Dec;51(12):1091-3.
Epinephrine maculopathy is a reversible macular change that occurs in aphakic eyes being treated with topical epinephrine compounds. The first symptom is transient blurred vision, which can be followed by decreased visual acuity, flame-shaped hemorrhages, and cystoid macular edema. Onset of symptoms can range from a few days after the commencement of epinephrine therapy to several months thereafter. Epinephrine maculopathy should be differentiated from Irvine-Gass syndrome. Treatment consists of changing the patient's therapeutic regimen for glaucoma to other pharmaceutical agents. When this is done recovery of pre-maculopathy visual acuity and reversal of cystic macular changes usually occur.
肾上腺素性黄斑病变是一种可逆性黄斑改变，发生在用局部肾上腺素化合物治疗的无晶状体眼中。首发症状是短暂性视力模糊，随后可能出现视力下降、火焰状出血和黄斑囊样水肿。症状的出现时间可从肾上腺素治疗开始后的几天至数月不等。肾上腺素性黄斑病变应与 Irvine-Gass 综合征相鉴别。治疗方法是将患者的青光眼治疗方案改为其他药物。这样做后，黄斑病变前的视力通常会恢复，黄斑囊性改变也会逆转。
